Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
Recenti Progressi in Medicina|November 7, 2001
[Prevalence of anemia in oncologic patients treated with chemotherapy. Italian survey at the national level]G Bernardo, M Aglietta, D Amadori, et al.Neurology|March 3, 2010
Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trialA Pace, D Giannarelli, E Galiè, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative GroupJ Verweij, P H de Mulder, A de Graeff, et al.Gynecologic Oncology|December 14, 2012
A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)F Cognetti, A Bagnato, N Colombo, et al.European Journal of Cancer (Oxford, England : 1990)|April 22, 2008
P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevanceA Torsello, C Garufi, M Cosimelli, et al.Journal of Experimental & Clinical Cancer Research : CR|May 20, 2004
The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II studyA Fabi, M Barduagni, V Ferraresi, et al.Oncology|November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trialS Pignata, G Scambia, A Savarese, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2007
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancerE Bria, P Visca, F Novelli, et al.Tumori|December 23, 1998
Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trialF Boccardo, A Rubagotti, L Canobbio, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive diseaseP Papaldo, A Fabi, G Ferretti, et al.Pageof 9